Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

LUNA3 Phase III Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial of the Oral BTK Inhibitor Rilzabrutinib in Adults and Adolescents with Persistent or Chronic Immune Thrombocytopenia

David J. Kuter, James B Bussel, Nichola Cooper, Terry Gernsheimer, Michele P. Lambert, Howard Liebman, Michael D Tarantino, Olga Bandman, Puneet Arora, Ann Neale, Regan Burns, Mengjie Yao, Waleed Ghanima

Blood (2021) 138 (Supplement 1): 1010.

https://doi.org/10.1182/blood-2021-144504

Published: 2021

Journal Articles

Tapering Thrombopoietin Receptor Agonists in Primary Immune Thrombocytopenia: Recommendations Based on the RAND/UCLA Modified Delphi Panel Method

Adam Cuker, MD, Jenny M. Despotovic, DO, Rachael F. Grace, MD, Caroline Kruse, Michele P. Lambert, MD MSTR, Howard Liebman, MD, Roger M. Lyons, MD, Keith R McCrae, MD, Vinod A. Pullarkat, MD, Jeffrey Wasser, MD, David Beenhouwer, MD, Sarah N Gibbs, MPH, Irina Yermilov, MD MPH, MS, Michael S Broder, MD MSHS

Blood (2020) 136 (Supplement 1): 6–8.

https://doi.org/10.1182/blood-2020-133262

Published: 2020

Journal Articles

Ethnic and Racial Difference In H.Pylori Infection In Patients With ITP Treated At A MAJOR Tertiary Medical Center In LOS Angeles

Caitlin M O'Neill, BA, Ulysses Gomez, BA, Ilene C Weitz, MD, Casey O'Connell, MD, Howard Liebman, MD

Blood (2013) 122 (21): 3548.

https://doi.org/10.1182/blood.V122.21.3548.3548

Published: 2013

Journal Articles

Romiplostim For Thrombocytopenia in Patients with Hepatitis C (HCV)-Associated Liver Disease: Preliminary Report Of An Ongoing Clinical Trial

Howard Liebman, MD, Laurie Hornor, BA, Tse-Ling Fong, MD, Casey O'Connell, MD, Ilene C Weitz, MD

Blood (2013) 122 (21): 3555.

https://doi.org/10.1182/blood.V122.21.3555.3555

Published: 2013

Journal Articles

Comparison Of Two Dosing Schedules For Subcutaneous Injections Of Low-Dose Anti-CD20 Veltuzumab In Relapsed Immune Thrombocytopenia: Final Results Of a Phase I Study

Howard Liebman, MD, James B Bussel, MD, Mansoor N Saleh, MD, Heather Horne, William A Wegener, MD, PhD, David M Goldenberg, ScD, MD

Blood (2013) 122 (21): 1080.

https://doi.org/10.1182/blood.V122.21.1080.1080

Published: 2013

Journal Articles

Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group

Blood (2013) 121 (14): 2596–2606.

https://doi.org/10.1182/blood-2012-07-442392

Published: 2013

Includes: Supplemental data

Journal Articles

A Novel Hybrid CFH/CFHR1–3 Gene in Atypical Hemolytic Uremic Syndrome

Mehmet F. Hepgur, MD, Preeti Chaudhary, MD, Sarmen Sarkissian, MD, Richard J. H. Smith, MD, Howard Liebman, MD, Ilene C Weitz, MD

Blood (2012) 120 (21): 4644.

https://doi.org/10.1182/blood.V120.21.4644.4644

Published: 2012

Journal Articles

Tinzaparin Is Effective and Safe for the Treatment and Extended Secondary Prophylaxis In Cancer Patients with Venous Thromboembolism.

Scott T Tagawa, MD, Ilene c Weitz, MD, Casey L. O'Connell, MD, Leanne Rochanda, MS, Mckenna Archer, David I Quinn, MD, PhD, Howard Liebman, MD

Blood (2010) 116 (21): 1104.

https://doi.org/10.1182/blood.V116.21.1104.1104

Published: 2010

Journal Articles

Subcutaneous Injections of Low-Dose Anti-CD20 Veltuzumab for Treatment of Relapsed Immune Thrombocytopenia (ITP).

Mansoor N Saleh, MD, Howard Liebman, MD, Zale P. Bernstein, MD, O. George Negrea, MD, James B. Bussel, MD, Anthony C. Onyegbula, DO, Charles M Farber, MD, PhD, Rashid Abassi, MD, Thomas M. Cosgriff, MD, Kenneth Pennington, MD, Heather Horne, Nick Teoh, PhD, Asraf Gomaa, William A Wegener, MD, PhD, David M Goldenberg, ScD, MD

Blood (2009) 114 (22): 1322.

https://doi.org/10.1182/blood.V114.22.1322.1322

Published: 2009

Journal Articles

Long-Term Safety Profile of Romiplostim in Patients with Chronic Immune Thrombocytopenia (ITP).

Howard Liebman, MD, FACP, David Henry, MD, Francois Lefrere, MD, Jean-Francois Viallard, MD, Alan Lichtin, MD, James George, MD, Miguel Sanz, MD, PhD, Kathy Zhang, PhD, Mark Rutstein, MD

Blood (2008) 112 (11): 3415.

https://doi.org/10.1182/blood.V112.11.3415.3415

Published: 2008

Journal Articles

Unsuspected Pulmonary Emboli Identified on Routine Cancer Staging MDCT Scans: Impact on Cancer Survival

Casey L O’Connell, MD, Mohammad Ghalichi, MD, Soames Boyle, MD, Sheila Vasan, MD, William Boswell, MD, Pedram Razavi, MD, MPH, Kristen Grabow, Lisa Mark, PA, Amy Caton, MD, Howard Liebman, MD

Blood (2008) 112 (11): 3818.

https://doi.org/10.1182/blood.V112.11.3818.3818

Published: 2008

Journal Articles

Eculizumab Therapy Results in Rapid and Sustained Decreases in Markers of Thrombin Generation and Inflammation in Patients with PNH

Ilene Ceil Weitz, MD, Michael Ghods, BA, Leanne Rochanda, MS, Pedram Prazavi, MD, Jeffrey Zwicker, MD, Bruce Furie, MD, Howard Liebman, MD

Blood (2008) 112 (11): 407.

https://doi.org/10.1182/blood.V112.11.407.407

Published: 2008

NARROW

LUNA3 Phase III Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial of the Oral BTK Inhibitor Rilzabrutinib in Adults and Adolescents with Persistent or Chronic Immune Thrombocytopenia

Tapering Thrombopoietin Receptor Agonists in Primary Immune Thrombocytopenia: Recommendations Based on the RAND/UCLA Modified Delphi Panel Method

Ethnic and Racial Difference In H.Pylori Infection In Patients With ITP Treated At A MAJOR Tertiary Medical Center In LOS Angeles

Romiplostim For Thrombocytopenia in Patients with Hepatitis C (HCV)-Associated Liver Disease: Preliminary Report Of An Ongoing Clinical Trial

Comparison Of Two Dosing Schedules For Subcutaneous Injections Of Low-Dose Anti-CD20 Veltuzumab In Relapsed Immune Thrombocytopenia: Final Results Of a Phase I Study

Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group

A Novel Hybrid CFH/CFHR1–3 Gene in Atypical Hemolytic Uremic Syndrome

Tinzaparin Is Effective and Safe for the Treatment and Extended Secondary Prophylaxis In Cancer Patients with Venous Thromboembolism.

Subcutaneous Injections of Low-Dose Anti-CD20 Veltuzumab for Treatment of Relapsed Immune Thrombocytopenia (ITP).

Long-Term Safety Profile of Romiplostim in Patients with Chronic Immune Thrombocytopenia (ITP).

Unsuspected Pulmonary Emboli Identified on Routine Cancer Staging MDCT Scans: Impact on Cancer Survival

Eculizumab Therapy Results in Rapid and Sustained Decreases in Markers of Thrombin Generation and Inflammation in Patients with PNH

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only